FDA Warns of Serious Lung Condition in Infants Treated with Proglycem
In a recent drug safety alert, the Food and Drug Administration (FDA) warned that a serious lung condition, pulmonary hypertension, has been reported in infants and newborns treated with Proglycem (diazoxide) for low blood sugar. Pulmonary hypertension is high pressure in the blood vessels leading to the lungs. The FDA identified … [Read more...] about FDA Warns of Serious Lung Condition in Infants Treated with Proglycem
FDA Infants taking Proglycem Warning
The Risk Of Proglycem to Children. Proglycem, a drug used to treat low blood sugar, has been associated with reports of pulmonary hypertension in infants and newborns taking the medication, the U.S. Food and Drug Administration (FDA) warned. Pulmonary hypertension is a serious lung condition where there is high blood pressure in … [Read more...] about FDA Infants taking Proglycem Warning
